CLARIS LIFESCIENCES LIMITED DELISTED SHARE
Founded on 19 July 1994, Claris Lifesciences Limited is a Public Limited Company it is involved in Human Healthcare Activities. It is registered at the registrar of companies in Ahmedabad. Authorized equity capital of company is Rs. 1,205,100,030 and paid-up capital is Rs. 545,677,630.
Shares of Claris Lifesciences Limited were listed on the BSE. The company's shares stopped trading on BSE on March 15, 2018, and it was delisted from the BSE on March 22, 2018. The exit offer price was Rs. 400 per share for public shareholders.
INCORPORATION DETAILS
CIN | U85110GJ1994PLC022543 |
Registration Date | 19 July 1994 |
Company Name | Claris Lifesciences Limited |
Email Address | secretarial@claris.in |
GST Number | 24AAACC6366Q1Z8 |
Category/Sub-category of the Company | Company Limited by Shares / Non-Government Company |
Class of Company | Public |
Listing status | Unlisted |
Registration Number | 22543 |
Statutory Auditors | Shah & Shah Associates, Ahmedabad |
Address of the Registered office & contact details | Claris Corporate Headquarters, Nr. Parimal Railway Crossing, Ellisbridge, Ahmedabad - 380 006, India. |
Company Secretary & Compliance Officer | Mr. Kirit H. Kanjaria. |
Name, Address & contact details of the Registrar & Transfer Agent, if any | LINK INTIME INDIA PRIVATE LIMITED (Unit: Claris Lifesciences Limited) C-101, 247 Park, L B S Marg, Vikhroli (West), Mumbai - 400 083. |
PARTICULAR OF SUBSIDIARY COMPANIES
S. No. | Name of the Company | Subsidiary | % of shares held |
Foreign Subsidiaries | |||
1. | Claris Life Sciences Venezuela C.A. | Subsidiary | 100% |
2. | PT. Claris Life Sciences Indonesia | Subsidiary | 100% |
BOARD OF DIRECTORS
Mr. Surrinder Lal Kapur (Chairman & Non-Executive and Independent Director)
Mr. Arjun Handa (Vice-Chairman & Managing Director)
Mr. Aditya S. Handa (Non-Executive and Non-Independent Director)
Mr. Chandrasingh S. Purohit (Whole Time Director & CFO)
Mr. Shyamsunder Sharma (Non-Executive and Non-Independent Director)
Dr. Anup P. Shah (Non-Executive and Independent Director)
SHAREHOLDING PATTERN
(As of 31-03-2021)
S. No. | Shareholder’s Name | No. of Shares | % of total Shares of the company |
1 | Promoter and Promoters Group | 5,41,80,079 | 99.28% |
2 | Public | 3,87,686 | 0.72% |
| Total | 5,45,67,765 | 100% |
PROFIT & LOSS STATEMENT OF CLARIS LIFESCIENCES LIMITED (Rs. In Lacs)
(As of 31-03-2018 to 31-03-2021)
PARTICULARS | 2021 | 2020 | 2019 | 2018 |
INCOME | ||||
Other income | 4.13 | 45.92 | 762.61 | 1,391.78 |
Total income | 4.13 | 45.92 | 762.61 | 1,391.78 |
EXPENSES | ||||
Finance costs | 0.04 | 0.22 | - | - |
Other expenses | 31.39 | 145.49 | 1,246.98 | 1,793.80 |
Depreciation and amortization expense | - | - | - | 10.31 |
Total expenses | 31.43 | 145.71 | 1,246.98 | 1,804.11 |
Profit/(Loss) before tax | (27.30) | (99.79) | (484.37) | (412.33) |
Tax expense / (benefit) |
|
| ||
Adjustment of tax relating to earlier years | - | (26.92) | - | 449.77 |
Deferred tax expense | - | 428.37 | 264.70 | (278.63) |
Current tax | - | - | - | - |
Total tax expense / (benefit) | - | 401.45 | 264.70 | 171.14 |
Profit/(Loss) for the year from continuing operations | - | - | (749.07) | (583.47) |
Profit before share in loss of Associate and tax from Discontinued operations | - | - | - | 3,249.82 |
Tax Expense of Discontinued operations | - | - | - | 1,110.18 |
Net Profit / (Loss) for the year from discontinued operations | - | - | - | 2,139.64 |
Profit / (Loss) for the year | (27.30) | (501.24) | (749.07) | 1,556.17 |
Other comprehensive income | ||||
Items that will be reclassified to profit and loss | ||||
Exchange differences in translating the financial statements of a foreign operation | - | - | 41.04 | 0.08 |
Income tax effect on above | - | - | - | - |
Total comprehensive income / (loss) for the year | (27.30) | (501.24) | (708.02) | 1,556.25 |
Profit for the year from continuing operations attributable to : | ||||
Owners of the company | - | - | (749.07) | (583.47) |
Non-controlling interest | - | - | - | - |
- | - | (749.07) | (583.47) | |
Profit for the year from discontinued operations attributable to : | ||||
Owners of the company | - | - | - | 2,283.19 |
Non-controlling interest | - | - | - | (143.55) |
- | - | - | 2,139.64 | |
Profit / (Loss) for the year attributable to : | ||||
Equity holders of the parent | (27.30) | (501.24) | - | - |
Owners of the company | - | - | (749.07) | 1,699.72 |
Non-controlling interest | - | - | - | (143.55) |
(27.30) | (501.24 | (749.07) | 1,556.17 | |
Other comprehensive income/(loss) for the year attributable to | ||||
Equity holders of the parent | - | - | - | - |
Owners of the company | - | - | 41.04 | 5.51 |
Non-controlling interest | - | - | - | (5.43) |
- | - | 41.04 | 0.08 | |
Total comprehensive income / (loss) for the year, net of tax | ||||
Equity holders of the parent | (27.30) | (501.24) | - | - |
Owners of the company | - | - | (708.02) | 1,705.23 |
Non-controlling interest | - | - | - | (148.98) |
(27.30) | (501.24) | (708.02) | 1,556.25 | |
Earnings per equity share of Rs.10 each | ||||
Earnings per equity share (Basic) | (0.05) | (0.92) | - | - |
Earnings per equity share (Diluted) | (0.05) | (0.92) | - | - |
Continuing Operations | - | - | (1.37) | (1.07) |
Discontinued Operations | - | - | - | 4.18 |
Continuing & Discontinued Operations | - | - | (1.37) | 3.11 |
BALANCE SHEET OF CLARIS LIFESCIENCES LIMITED (Rs. In Lacs)
(As of 31-03-2018 to 31-03-2021)
PARTICULARS | 2021 | 2020 | 2019 | 2018 |
ASSETS | ||||
Non-current assets | ||||
Deferred tax assets (net) | 527.85 | 527.85 | 956.21 | 1,220.91 |
Income tax assets (net) | 104.89 | 104.78 | - | - |
Non-current tax assets (net) | - | - | 634.64 | 626.74 |
Property, plant, and equipment | - | - | - | - |
Capital work-in-progress | - | - | - | - |
Intangible assets | - | - | - | - |
Financial assets | ||||
Investments | - | - | - | - |
TOTAL | 632.74 | 632.63 | 1,590.85 | 1,847.65 |
Current assets | ||||
Financial assets | ||||
Trade receivables | - | - | 62.68 | 58.10 |
Cash and cash equivalents | 11.63 | 18.11 | 27.43 | 6.88 |
Other bank balances | 36.02 | 38.87 | 38.38 | 31.60 |
Other financial assets | 258.76 | 269.69 | 341.95 | 131.62 |
Other current assets | 39.44 | 39.18 | 111.98 | 326.89 |
TOTAL CURRENT ASSETS | 345.85 | 365.85 | 582.42 | 555.09 |
TOTAL ASSETS | 978.59 | 998.48 | 2,173.27 | 2,402.74 |
EQUITY AND LIABILITIES EQUITY | ||||
Equity share capital | 5,456.78 | 5,456.78 | 5,456.78 | 5,456.78 |
Other equity | (6,622.90) | (6,595.60) | (6,094.36) | (5,386.34) |
TOTAL EQUITY | (1,166.12) | (1,138.82) | (637.58) | 70.44 |
LIABILITIES | ||||
Current liabilities | ||||
Financial liabilities | ||||
Borrowings | 2,101.30 | 2,097.30 | - | - |
Trade payables | ||||
Total outstanding dues of micro-enterprises and small enterprises | 0.54 | - | - | - |
Total outstanding dues of creditors other than micro-enterprises and small enterprises | 34.86 | 25.04 | 24.56 | 192.04 |
Other financial liabilities | 4.88 | 12.43 | 2,783.91 | 2,003.68 |
Other current liabilities | 3.13 | 2.53 | 2.38 | 136.58 |
TOTAL CURRENT LIABILITIES | 2,144.71 | 2,137.30 | 2,810.85 | 2,332.30 |
TOTAL EQUITY AND LIABILITIES | 978.59 | 998.48 | 2,173.27 | 2,402.74 |
DIVIDEND AND RETAINED EARNINGS
(As of 31-03-2018 to 31-03-2019)
Particulars | 2021 | 2020 | 2019 | 2018 |
Dividend | Nil | Nil | Nil | Nil |
Retained Earnings (In Rs. Lakhs) | (6,622.90) | (6,595.60) | (6,181.03) | (5,431.96) |
PERFORMANCE OF THE COMPANY
Income decreased from Rs. 45.92 Lacs in FY 2020 to Rs. 4.13 Lacs in FY 2021, showing a decline of 91.01% as compared to the previous financial year.
Finance Cost has decreased from Rs. 0.22 Lacs in FY 2020 to Rs. 0.04 Lacs in FY 2021.
In FY 2021, Company’s Net Loss stood at Rs. 27.30 Lacs, as against Rs. 501.24 Lakh loss of FY 2020.
The Current Ratio of the company as of 31st March 2021 was 0.16%.
The debt to equity ratio of the company as of 31st March 2021 was 0.83%.
In the Financial Year 2020-21, the company has not paid dividends.
Powered by Froala Editor
